Many bought this stock to play the GLP-1 boom, but it has bigger opportunities to boost its share price
Instead of betting on which single pharmaceutical company wins a drug race, this company benefits as the industry grows by supplying the proprietary packaging.
We haven't written up this one. CNBC has the full story — the link below goes straight to it.



